Labor Market Pulse · Life Sciences · October 2026
Life Sciences Labor Market Report: Scranton--Wilkes-Barre, PA MSA — October 2026
Scranton life sci pay splits: analytics roles surge, regulatory lags.
Metro Clinical Data Manager pay climbed to $147,141, nearly $24,000 above the national median, while Regulatory Affairs Specialist pay fell to $92,000 — about 11% below the national figure — even as statewide pharma investment intensifies competition for compliance talent.
Free archive edition. Published by WageScape as sent to subscribers; data as of October 2026.
Key indicators
- Metro unemployment rate: 4.7% — vs 3.6% PA statewide, 4.1% national
- Regulatory Affairs pay gap: -$11,780 — Metro $92,000 vs national $103,780, down significantly
- Clinical Data Manager premium: +$23,488 — Metro $147,141 vs national $123,653
- PA statewide job postings growth: +213% YoY — August 2026, signals broad labor demand surge
Key takeaways
Regulatory affairs pay is falling here while demand rises statewide.
Metro advertised pay for Regulatory Affairs Specialist dropped significantly to $92,000, nearly 11% below the national median, even as GSK, Lilly and other PA pharma employers compete for the same compliance and quality talent pool. Falling local pay amid rising statewide demand for this skill set suggests risk of candidates commuting or relocating toward Lehigh Valley and Philadelphia openings.
Clinical Data Manager pay signals a premium for scarce analytics talent.
Metro median of $147,141 runs nearly $24,000 above the national figure and is rising significantly, consistent with national reporting that lab and R&D vacancy rates topped 23% in Q1 2026. Employers appear to be paying up for data management expertise that is difficult to source locally, prioritizing retention over competing purely on volume.
CRA pay gap with national market may widen outsourcing conversations.
Clinical Research Associate advertised pay sits at $81,895 locally against $90,065 nationally — a meaningful gap even as national CRA demand stays candidate-driven with employers largely holding or modestly growing headcount. A persistent local pay discount could push build-vs-outsource decisions further toward CRO partnerships for trial operations centered outside the metro.
Lab Technician wage softness contrasts with tightening upstream roles.
Metro Lab Technician pay fell moderately to $46,891 while higher-skill functions like Biostatistician and Clinical Data Manager posted gains, suggesting the local talent crunch is concentrated at the credentialed, advanced-degree tier instead of spreading across the scientific workforce broadly. Headcount planning may benefit from treating entry-level lab roles and specialized analytics roles as distinct labor markets with different pricing pressure.
Median advertised pay by role — Scranton--Wilkes-Barre, PA MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $91,135 | $129,610 | $144,690 | Significant increase | $130,339 |
| Clinical Research Associate * | $61,360 | $81,895 | $102,753 | Significant increase | $90,065 |
| Lab Technician * | $39,675 | $46,891 | $53,801 | Moderate decline | $47,840 |
| Regulatory Affairs Specialist * | $63,603 | $92,000 | $112,818 | Significant decline | $103,780 |
| Clinical Data Manager * | $97,701 | $147,141 | $178,812 | Significant increase | $123,653 |
| Biostatistician * | $105,167 | $138,727 | $159,035 | Moderate increase | $131,958 |
| Validation Engineer * | $88,981 | $105,698 | $110,396 | Stable | $106,478 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Pennsylvania's unemployment rate fell to 3.6% in September, its lowest since 2023, while the Scranton-Wilkes-Barre MSA continues to run hotter at 4.7% as of the most recent reading, reflecting the metro's heavier reliance on transportation, logistics and administrative employment over professional or scientific occupations. Statewide pharma and biotech capital commitments — including GSK's $800M expansion and Eli Lilly's Lehigh Valley buildout — are concentrated in the Philadelphia and Lehigh Valley corridors, leaving Scranton-area life sciences employers competing for the same thin regional pool of regulatory, quality and clinical talent without a local supply response.
What it means
Metro advertised pay for Regulatory Affairs Specialist ($92,000) sits roughly $12,000 below the national median and is down significantly year-over-year, a signal that local employers may be losing wage competitiveness precisely as eastern Pennsylvania's manufacturing investment wave intensifies demand for compliance and quality talent. Clinical Data Manager and Biostatistician roles, by contrast, show metro pay running above national medians — evidence that specialized, credential-heavy functions are pricing ahead of the broader market even in a smaller metro, likely reflecting employers paying a premium to retain scarce talent over competing on volume. Organizations should evaluate whether regulatory affairs compensation has drifted out of step with Lehigh Valley and Philadelphia-area offers, since candidates in commutable range have more leverage than metro-only benchmarks suggest.
Looking ahead
Early indicator: Watch whether Scranton-Wilkes-Barre's MSA unemployment rate, last at 4.7%, converges toward Pennsylvania's 3.6% statewide rate or continues diverging — a widening gap would reinforce that life sciences talent scarcity here is structural, tied to limited local R&D and clinical infrastructure over cyclical slack.
Expected: Pennsylvania job postings surged 213% year-over-year statewide, and Life Sciences Pennsylvania has flagged executive-level talent scarcity as a constraint on company formation. Scranton-area employers should expect continued upward pressure on VP-level quality and regulatory compensation as nearby metros absorb executive supply first.
Potential inflection point: GSK's five-year, 300-job expansion and Lilly's 850-person Lehigh Valley facility ramp toward 2031 hiring; both sit within commuting or relocation range of Scranton-area talent. Monitor whether these employers' hiring timelines begin pulling regulatory and manufacturing candidates out of the Scranton labor pool over the next two quarters.
Worth watching: Pennsylvania WARN filings show healthcare among the top three sectors for layoff notices statewide (22 notices, 3,813 workers over 24 months). Track whether any regional health system or diagnostics employer layoffs release clinical or lab talent into the Scranton-area candidate pool.
Sources
- U.S. Bureau of Labor Statistics — Scranton-Wilkes-Barre MSA unemployment rate at 4.7% in July 2026
- Pennsylvania Department of Labor & Industry — Pennsylvania unemployment rate fell to 3.6% in September 2026, lowest since 2023
- GSK corporate announcement — GSK's $800M PA expansion creating 300+ jobs over five years
- Eli Lilly corporate announcement — Eli Lilly Lehigh Valley injectable facility targeting 850 jobs by 2031
- Life Sciences Pennsylvania — Pennsylvania job postings up 213% year-over-year in August 2026
- Industry labor market research — Lab/R&D vacancy reached 23.2% across top 13 U.S. life sciences markets Q1 2026
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.